Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-29
2008-01-29
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S307000, C514S352000, C546S125000, C546S148000, C546S304000
Reexamination Certificate
active
07323474
ABSTRACT:
The invention relates to pyridine derivatives of formula (I)wherein the substituents and symbols are defined as indicated in the description, processes for the preparation thereof, their usage in the preparation of a pharmaceutical composition for the treatment of a disease which responds to an inhibition of angiogenesis, and pharmaceutical compositions containing such compounds.
REFERENCES:
patent: 3847919 (1974-11-01), Knowles et al.
patent: 4405790 (1983-09-01), McGill et al.
patent: 5654307 (1997-08-01), James et al.
patent: 6706731 (2004-03-01), Bold et al.
patent: WO 97/34876 (1997-09-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO 98/13354 (1998-04-01), None
patent: WO 98/35958 (1998-08-01), None
Kowalski, Journal of Heterocyclic Chemistry, vol. 31, No. 1, pp. 245-247, Jan.-Feb. 1994.
Bold Guido
Manley Paul W
Davis Zinna N.
Novartis AG
LandOfFree
Pyridine derivatives inhibiting angiogenesis and/or VEGF... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine derivatives inhibiting angiogenesis and/or VEGF..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives inhibiting angiogenesis and/or VEGF... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2770098